NEW ANGIOTENSIN II RECEPTOR BLOCKER AZILSARTAN MEDOXOMIL: COMPARISON TO VALSARTAN

被引：2
|
作者：
Sica, D. [1 ]
White, W. B. [2 ]
Weber, M. A. [3 ]
Bakris, G. L. [4 ]
Perez, A. [5 ]
Cao, C. [5 ]
Kupfer, S. [5 ]
机构：
[1] Virginia Commonwealth Univ Hlth Syst, Richmond, VA USA
[2] Univ Connecticut, Sch Med, Farmington, CT USA
[3] SUNY Downstate Coll Med, New York, NY USA
[4] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA
[5] Takeda Global Res & Dev, Deerfield, IL USA
来源：
JOURNAL OF HYPERTENSION | 2010年 / 28卷
关键词：
D O I：
10.1097/01.hjh.0000379014.10568.aa
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：E276 / E276
页数：1
相关论文
共 50 条
  • [31] Azilsartan, New Angiotensin II Type 1 Receptor Blocker, Would Suppress Morning Surge in Hypertension
    Isegawa, Kengo
    Hirooka, Yoshitaka
    Kishi, Takuya
    Sunagawa, Kenji
    FASEB JOURNAL, 2013, 27
  • [32] A novel molecule of the angiotensin II receptor blocker class: Focus on olmesartan medoxomil
    Volpe M.
    Trimarco B.
    High Blood Pressure & Cardiovascular Prevention, 2005, 12 (2) : 79 - 89
  • [33] Dose-responsive antihypertensive efficacy of valsartan, a new angiotensin II-receptor blocker
    Pool, J
    Oparil, S
    Hedner, T
    Glazer, R
    Oddou-Stock, P
    Hester, A
    CLINICAL THERAPEUTICS, 1998, 20 (06) : 1106 - 1114
  • [34] New Angiotensin II Type 1 Receptor Blocker, Azilsartan, Attenuates Cardiac Remodeling after Myocardial Infarction
    Nakamura, Yuichi
    Suzuki, Satoshi
    Saitoh, Shu-ichi
    Takeishi, Yasuchika
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2013, 36 (08) : 1326 - 1331
  • [35] Effects of olmesartan medoxomil as an angiotensin II-receptor blocker in chronic hypoxic rats
    Nakamoto, T
    Harasawa, H
    Akimoto, K
    Hirata, H
    Kaneko, H
    Kaneko, N
    Sorimachi, K
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 528 (1-3) : 43 - 51
  • [36] Olmesartan medoxomil (CS-866) - An angiotensin II receptor blocker for treatment of hypertension
    Song, JC
    White, CM
    FORMULARY, 2001, 36 (07) : 487 - +
  • [37] Azilsartan - New Representative of the Class of Angiotensin Receptor Blockers II
    Ostroumova, O. D.
    KARDIOLOGIYA, 2014, 54 (09) : 65 - 71
  • [38] The angiotensin II type 1 receptor blocker valsartan attenuates graft vasculopathy
    Tetsufumi Yamamoto
    Masataka Sata
    Daiju Fukuda
    Shinichi Takamoto
    Basic Research in Cardiology, 2005, 100 : 84 - 91
  • [39] Application of AT1-Angiotensin II Receptor Blocker Valsartan in Clinical Practice
    Maximov, M. L.
    Mochkin, I. A.
    Starodubtsev, A. K.
    KARDIOLOGIYA, 2011, 51 (08) : 77 - 84
  • [40] Angiotensin II type 1 receptor blocker, valsartan, ameliorates insulin resistance
    Shiuchi, T
    Cui, TX
    Wu, L
    Matsubara, Y
    Li, JM
    Ming, LJ
    Iwai, M
    Horiuchi, M
    JOURNAL OF HYPERTENSION, 2002, 20 : S60 - S61
12345